Jan. 5 at 7:22 PM
$JFU The best part is the narrative is easy for traders to repeat without lying, ~2,000 patient US study, UK and Swiss regulatory progress, insurer channel at 15+ partners, >1M user digital distribution, pancreatic stats with 285 and 30-subject cohorts, it’s a receipts story, company name in bio 🔥